Clicky

DexCom Inc(DC4)

Description: DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.


Keywords: Diabetes Healthcare Providers FDA Blood Test Blood Glucose Monitoring Diabetes Management G7 Continuous Glucose Monitor Software Developers Diabetes Treatment Insulin Pump Cgm

Home Page: www.dexcom.com

6340 Sequence Drive
San Diego, CA 92121
United States
Phone: 858 200 0200


Officers

Name Title
Mr. Kevin Ronald Sayer Executive Chairman, CEO & President
Mr. Jereme M. Sylvain CPA Executive VP, CFO & Chief Accounting Officer
Mr. Jacob Steven Leach Executive VP & COO
Mr. Michael Jon Brown Executive VP & Chief Legal Officer
Mr. Girish Naganathan Executive VP & CTO
Mr. Sean Christensen Director of Corporate Affairs & Head of Investor Relations
Mr. Matthew Dolan Executive Vice President of Strategy, Corporate Development & Dexcom Labs
Ms. Leverne Marsh Executive Vice President of Marketing
Ms. Sadie M. Stern Executive VP & Chief Human Resources Officer
Mr. Donald M. Abbey Executive Vice President of Global Business Services, Quality & Regulatory Affairs

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 38.3142
Trailing PE: 47.641
Price-to-Book MRQ: 15.5271
Price-to-Sales TTM: 7.4164
IPO Date:
Fiscal Year End: December
Full Time Employees: 9500
Back to stocks